Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Township, MI
Last reviewed: May 2026

| Stage / Grade | Radiographic Finding | Symptoms | ROM Remaining | Treatment Tier |
|---|---|---|---|---|
| Grade I (Mild) | Joint space narrowing <25%; minor osteophytes | Mild pain with prolonged activity; minimal swelling | Near normal | Orthotics, PT, NSAIDs, cortisone injection |
| Grade II (Moderate) | 25–50% joint space loss; subchondral sclerosis; osteophyte formation | Moderate pain; stiffness after rest; activity limitation | Reduced 20–40% | Bracing, hyaluronic acid, PRP; consider debridement/cheilectomy |
| Grade III (Severe) | 50–75% joint space loss; cysts; anterior impingement | Severe pain; antalgic gait; limited tolerance for walking | Markedly reduced | Distraction arthroplasty; consider TAR or fusion |
| Grade IV (End-Stage) | Bone-on-bone; complete joint space loss; deformity | Constant pain; disability; severe gait disturbance | Minimal to none | Total Ankle Replacement (TAR) vs ankle arthrodesis |
| Valgus / Varus Deformity | Coronal plane malalignment >10° | Edge loading; rapid progression; instability | Variable | May require osteotomy before or at time of TAR/fusion |
| Surgical Option | Best Candidate | Prosthesis / Technique | Outcome | Revision / Longevity |
|---|---|---|---|---|
| Ankle Arthrodesis (Fusion) | Young active patients; severe deformity; failed TAR; avascular necrosis | Tibiotalar fusion with screws or nail; allograft for bone loss | 85–95% pain relief; excellent durability | Lifelong; adjacent joint OA risk at 10–20 years |
| Total Ankle Replacement (TAR) | Lower-demand patients ≥55 years; good bone stock; well-aligned ankle | 3rd-gen TAR (STAR, Infinity, Cadence); bone-sparing cementless design | 80–90% good-to-excellent at 5 years | 85–90% implant survival at 10 years; revision to fusion if failure |
| Distraction Arthroplasty | Grade III; younger patients wanting to delay fusion; some cartilage remaining | External fixator distraction 5mm for 3 months; allows fibrocartilage regrowth | 60–70% improvement; buys 5–7 years | Bridging procedure; majority eventually need TAR or fusion |
| Supramalleolar Osteotomy | Varus/valgus ankle with eccentric loading; Grade I–II with malalignment | Corrective tibial osteotomy to redistribute load | 75–85% improvement in Grade I–II | Slows progression; may allow TAR later |
| Ankle Debridement / Cheilectomy | Grade I–II with anterior impingement; younger patients | Arthroscopic or open osteophyte removal | 60–75% short-term; progression continues | Temporizing; 3–5 year benefit before advancing OA |
Quick answer: Ankle Arthritis End Stage Michigan Podiatrist is a common foot/ankle topic that affects many patients. The 2026 evidence-based approach combines proper diagnosis, conservative-first treatment, and escalation only when needed. We treat this regularly at our Howell and Bloomfield Township practices. Call (810) 206-1402.
Foot pain isn't resolving?
Same-week appointments at Howell & Bloomfield Township
Medically Reviewed | Dr. Tom Biernacki, DPM | Board-Certified Podiatric Surgeon | Balance Foot & Ankle, Michigan

Watch: How to Regrow Cartilage & Reverse OsteoArthritis? [Can We Do It?] — MichiganFootDoctors YouTube
End-stage ankle arthritis — the progressive loss of tibiotalar joint cartilage that culminates in bone-on-bone pain limiting ambulation — represents one of the most significant musculoskeletal disabilities, producing pain and functional limitation equivalent to severe hip arthritis while affecting a joint that receives the highest force per unit area of any joint in the body (3-5x body weight during walking). Unlike hip and knee arthritis, ankle arthritis is primarily post-traumatic — the consequence of prior ankle fractures, chronic instability, or osteochondral injuries rather than primary osteoarthritis. At Balance Foot & Ankle PLLC, Dr. Tom Biernacki manages the full spectrum of ankle arthritis from conservative treatment to surgical consultation for ankle arthrodesis and total ankle replacement.
Conservative Management of Ankle Arthritis
Conservative management of ankle arthritis aims to reduce pain, improve function, and delay surgical intervention: Ankle bracing: An Arizona brace (custom leather gauntlet ankle brace) or carbon fiber ankle-foot orthosis (AFO) limits ankle range of motion, reducing the bone-on-bone impaction that generates pain during walking. The Arizona brace is the most effective single non-surgical intervention for tibiotalar arthritis — many patients achieve 2-5 years of functional improvement with custom brace management. Anti-inflammatory medications: NSAIDs provide modest symptomatic benefit for arthritic joint pain — more effective for inflammatory arthritis (RA, gout) than for mechanical post-traumatic arthritis. Topical diclofenac gel may provide local benefit with lower systemic exposure. Corticosteroid injection: Intra-articular corticosteroid provides temporary relief (3-6 months) by reducing synovial inflammation; appropriate for acute flares and as a bridge to surgical planning. Repeated injection degrades cartilage — limiting to 2-3 per year. PRP injection: Autologous platelet-rich plasma intra-articular injection — limited but growing evidence for pain reduction in knee OA; evidence in ankle arthritis is emerging. Visco-supplementation (hyaluronic acid): Less evidence than in knee OA; off-label use for ankle arthritis.
Ankle Arthrodesis vs. Total Ankle Replacement
When conservative management fails to provide acceptable function, the decision between ankle arthrodesis (fusion) and total ankle replacement (TAR) is the central surgical planning question: Ankle arthrodesis (fusion): Permanent elimination of ankle motion through bone bridging — the tibia, fibula, and talus are compressed together with screws, locking the joint in a neutral position. Pain relief is reliable (85-90%) and durable. Downside: loss of ankle dorsiflexion and plantarflexion motion forces the adjacent subtalar and midtarsal joints to compensate — producing progressive arthritis in these joints over 10-15 years (the primary long-term complication of ankle fusion). Preferred for: younger, high-activity patients, patients with significant deformity, poor bone quality, or prior failed TAR. Total ankle replacement: Metallic and polyethylene components resurface the tibiotalar joint, preserving motion. Modern 3rd-generation implants (STAR, INFINITY, HINTEGRA) achieve 80-85% pain relief with 85-90% 10-year survivorship. Preferred for: older lower-demand patients, bilaterally affected patients, patients with inflammatory arthritis, and patients who refuse arthrodesis. Revision options are more limited than ankle fusion — failed TAR often requires revision to fusion. Adjacent joint protection: TAR preserves ankle motion, reducing the compensatory load on subtalar and midtarsal joints — this is the primary long-term advantage over fusion.
Post-Traumatic Ankle Arthritis Prevention
Because ankle arthritis is primarily post-traumatic, prevention centers on optimal management of the inciting injury: Ankle fractures: Anatomic reduction and fixation of ankle fractures — restoring the tibiotalar joint surface within 1-2mm — significantly reduces post-traumatic arthritis risk. Malreduced fractures that allow even 1mm of talar shift produce 40% reduction in contact area and proportional increase in contact pressure. Chronic ankle instability: Untreated lateral ankle ligament insufficiency allows repetitive abnormal talar motion that erodes articular cartilage over 10-20 years. Appropriate ligament reconstruction (modified Broström) prevents the mechanical joint damage that leads to end-stage arthritis. Osteochondral lesions: Cartilage defects of the talus (OCD lesions) require appropriate treatment — microfracture, OAT/OATS, or autologous chondrocyte implantation — to prevent the progressing cartilage loss that accelerates to end-stage arthritis.
Dr. Tom's Product Recommendations
Arizona AFO Custom Ankle Brace — Arthritis Support
⭐ Highly Rated
Semi-rigid ankle brace for end-stage ankle arthritis management — restricts tibiotalar joint motion to reduce bone-on-bone impaction pain during walking, commonly used as the primary conservative intervention before surgical planning.
Dr. Tom says: “My podiatrist prescribed an ankle brace for my ankle arthritis and the motion restriction reduced my walking pain enough to delay surgery by 2 years while I planned my timeline.”
Ankle arthritis brace, tibiotalar joint restriction, end-stage arthritis conservative management
Off-the-shelf braces provide partial tibiotalar restriction — custom Arizona or carbon fiber AFO provides superior motion control for end-stage arthritis
Disclosure: We earn a commission at no extra cost to you.
New Balance 928v3 Extra-Depth Walking Shoe
⭐ Highly Rated
Extra-depth walking shoe with rocker-bottom sole option — recommended for ankle arthritis patients to accommodate custom AFO or orthotic bracing while providing forefoot rocker that reduces ankle dorsiflexion demand during walking.
Dr. Tom says: “My podiatrist recommended extra-depth shoes for my ankle arthritis to fit my custom brace and the rocker sole reduced the ankle stress on each step.”
Ankle arthritis footwear, AFO accommodation shoe, rocker sole joint protection walking
Rocker-sole shoes for ankle arthritis require appropriate extra depth for any orthotic or brace accommodation
Disclosure: We earn a commission at no extra cost to you.
✅ Pros / Benefits
- Custom Arizona brace or AFO delays surgical intervention 2-5 years with significant functional improvement
- Intra-articular PRP and corticosteroid provide pain relief bridges during conservative management
- Total ankle replacement preserves adjacent joint health vs. fusion long-term
- Ankle arthrodesis achieves reliable 85-90% pain relief with durable outcomes for high-demand patients
❌ Cons / Risks
- Ankle fusion eliminates ankle motion — adjacent joint arthritis is the primary long-term consequence
- Total ankle replacement revision options are more limited than fusion — patient selection is critical
- End-stage ankle arthritis from untreated instability or fractures is largely preventable with proper early management
Dr. Tom Biernacki’s Recommendation
Ankle arthritis is a different disease than hip and knee arthritis — it’s mostly post-traumatic, which means there’s a preventable component to a lot of the end-stage cases I see. Patients who come to me with bone-on-bone ankle arthritis often have a history of an ankle fracture that wasn’t perfectly reduced, or chronic instability that was treated as ‘just a sprain’ for 15 years. The brace conversation is the most important non-surgical discussion — an Arizona brace gives a lot of patients 2-4 years of functional improvement that changes their life trajectory and surgical timing significantly.
— Dr. Tom Biernacki, DPM | Board-Certified Podiatric Surgeon | Balance Foot & Ankle
Frequently Asked Questions
What is end-stage ankle arthritis?
End-stage ankle arthritis is advanced degeneration of the tibiotalar joint — the joint between the tibia (shinbone) and talus (ankle bone) — where the articular cartilage has been substantially or completely lost, producing bone-on-bone contact during weight-bearing. Unlike hip and knee arthritis (where primary osteoarthritis from aging is the most common cause), ankle arthritis is predominantly post-traumatic — occurring after ankle fractures, chronic ankle instability, or osteochondral (cartilage) injuries. Symptoms include deep ankle pain with activity, swelling, stiffness (especially morning stiffness), and progressive loss of ankle range of motion. X-ray shows joint space narrowing, osteophytes (bone spurs), and subchondral sclerosis.
What is the best treatment for end-stage ankle arthritis?
Treatment depends on the severity of arthritis and the patient’s functional demands. Conservative management — custom ankle brace (Arizona brace or AFO), activity modification, anti-inflammatory medications, and corticosteroid or PRP injection — is the first approach and often provides 2-5 years of functional improvement for appropriately selected patients. When conservative treatment fails, surgical options are ankle arthrodesis (fusion) or total ankle replacement. Fusion is more durable for high-demand patients but eliminates ankle motion. Total ankle replacement preserves motion and protects adjacent joints but has greater revision complexity. The choice between fusion and replacement involves shared decision-making based on age, activity level, bone quality, and patient priorities.
Is ankle fusion or ankle replacement better?
Neither ankle fusion nor total ankle replacement is universally superior — the best procedure depends on the individual patient’s age, activity demands, bone quality, deformity, and priorities. Ankle fusion produces reliable pain relief (85-90%) with excellent durability — appropriate for younger, more active patients and those with significant deformity or poor bone quality. The trade-off: loss of ankle motion and the development of adjacent joint arthritis over 10-15 years from compensatory overload. Total ankle replacement preserves ankle motion, reduces adjacent joint stress, and allows a more normal gait pattern. The trade-off: higher technical demands, more limited revision options, and slightly lower long-term survivorship in high-demand patients. Most surgeons agree: fusion for the young, active patient; replacement for the older, lower-demand patient.
Can ankle arthritis be reversed?
Established ankle arthritis cannot be reversed — lost articular cartilage does not regenerate. However, disease progression can be slowed through several interventions: optimal management of the underlying condition (lateral ligament reconstruction for instability, anatomic fracture reduction for post-traumatic arthritis, appropriate treatment of osteochondral lesions); weight management to reduce joint loading; activity modification to avoid high-impact activities that accelerate wear; and joint-protective footwear and orthotic devices. Emerging biologic interventions (PRP, mesenchymal stem cell injection) show early promise for symptom modification but have not demonstrated reliable cartilage regeneration. The goal of conservative management is delaying surgical intervention until the patient is at the optimal age and functional status for the chosen procedure.
Michigan Foot Pain? See Dr. Biernacki In Person
4.9★ rated | 1,123 Reviews | 3,000+ Surgeries
Same-week appointments · Howell & Bloomfield Township
📞 (810) 206-1402 Book Online →Frequently Asked Questions
When should I see a podiatrist?
If symptoms persist past 2 weeks, affect your normal activity, or are accompanied by red-flag symptoms (warmth, redness, swelling, inability to bear weight).
What does treatment cost?
Most diagnostic visits and conservative treatments are covered by Medicare and major insurers. Out-of-pocket costs vary by your specific plan.
How quickly can I get an appointment?
Most non-urgent cases see us within 5 business days. Urgent cases (sudden pain, possible fracture) typically same or next business day.
In-Office Treatment at Balance Foot & Ankle
If home treatment isn’t providing relief for your ankle arthritis end stage michigan podiatrist, our podiatry team at Balance Foot & Ankle can help with same-day evaluations and advanced in-office care.
OrthoInfo – AAOS: Arthritis of the Foot and Ankle
Ready to Get Relief?
Same-day appointments available in Howell & Bloomfield Township, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
Dr. Tom Biernacki, DPM is a board-certified foot & ankle surgeon (ABFAS & ABPM) at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has made him one of the most-followed foot & ankle educators on YouTube.